Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resverlogix Corp. J (TSE:RVX)
TSX:RVX
Holding TSE:RVX?
Track your performance easily
RVX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.04 - C$0.10
Previous CloseC$0.06
Volume28.31K
Average Volume (3M)91.84K
Market Cap
C$16.84M
Enterprise ValueC$29.25M
Total Cash (Recent Filing)$55.00K
Total Debt (Recent Filing)$8.94M
Price to Earnings (P/E)―
Beta-0.18
Next Earnings
Mar 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 04, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding274,816,238
10 Day Avg. Volume28,321
30 Day Avg. Volume91,844
Standard Deviation0.21
R-Squared0.03
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-0.20
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.17
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Resverlogix News
PremiumCompany Announcements
Resverlogix Showcases Apabetalone’s Heart Health Benefits
PremiumCompany Announcements
Resverlogix Secures Shareholder Approval and Debenture Extension
PremiumCompany Announcements
Resverlogix Amends Debenture Terms Amidst Therapy Development
PremiumCompany Announcements
Resverlogix Reschedules Shareholder MeetingOptions Prices
Currently, No data available
---
Ownership Overview
RVX FAQ
What was Resverlogix Corp. J’s price range in the past 12 months?
Resverlogix Corp. J lowest stock price was C$0.04 and its highest was C$0.10 in the past 12 months.
What is Resverlogix Corp. J’s market cap?
Currently, no data Available
When is Resverlogix Corp. J’s upcoming earnings report date?
Resverlogix Corp. J’s upcoming earnings report date is Mar 27, 2025 which is in 121 days.
How were Resverlogix Corp. J’s earnings last quarter?
Resverlogix Corp. J released its earnings results on Aug 14, 2024. The company reported -C$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.022.
Is Resverlogix Corp. J overvalued?
According to Wall Street analysts Resverlogix Corp. J’s price is currently Overvalued.
Does Resverlogix Corp. J pay dividends?
Resverlogix Corp. J pays a Notavailable dividend of C$0.4 which represents an annual dividend yield of N/A. See more information on Resverlogix Corp. J dividends here
What is Resverlogix Corp. J’s EPS estimate?
Resverlogix Corp. J’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Resverlogix Corp. J have?
Resverlogix Corp. J has 280,650,200 shares outstanding.
What happened to Resverlogix Corp. J’s price movement after its last earnings report?
Resverlogix Corp. J reported an EPS of -C$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 33.333%.
Which hedge fund is a major shareholder of Resverlogix Corp. J?
Currently, no hedge funds are holding shares in TSE:RVX
---
Resverlogix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.28%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.60%
Trailing 12-Months
Company Description
Resverlogix Corp. J
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
---
Technical Analysis
Revive Therapeutics
―
Reliq Health Technologies
―
Microbix Biosystms
―
Covalon Technologies
―
---